121 related articles for article (PubMed ID: 21520287)
1. Appetitive motivational deficits in individuals with Parkinson's disease.
Shore DM; Rafal R; Parkinson JA
Mov Disord; 2011 Aug; 26(10):1887-92. PubMed ID: 21520287
[TBL] [Abstract][Full Text] [Related]
2. Differential role of dopamine in emotional attention and memory: evidence from Parkinson's disease.
Hälbig TD; Assuras S; Creighton J; Borod JC; Tse W; Frisina PG; Voustianiouk A; Gracies JM; Olanow CW
Mov Disord; 2011 Aug; 26(9):1677-83. PubMed ID: 21638322
[TBL] [Abstract][Full Text] [Related]
3. Startling facts about emotion in Parkinson's disease: blunted reactivity to aversive stimuli.
Bowers D; Miller K; Mikos A; Kirsch-Darrow L; Springer U; Fernandez H; Foote K; Okun M
Brain; 2006 Dec; 129(Pt 12):3356-65. PubMed ID: 17095520
[TBL] [Abstract][Full Text] [Related]
4. Are dopaminergic pathways involved in theory of mind? A study in Parkinson's disease.
Péron J; Vicente S; Leray E; Drapier S; Drapier D; Cohen R; Biseul I; Rouaud T; Le Jeune F; Sauleau P; Vérin M
Neuropsychologia; 2009 Jan; 47(2):406-14. PubMed ID: 18845171
[TBL] [Abstract][Full Text] [Related]
5. Subthalamic nucleus stimulation affects incentive salience attribution in Parkinson's disease.
Serranová T; Jech R; Dušek P; Sieger T; Růžička F; Urgošík D; Růžička E
Mov Disord; 2011 Oct; 26(12):2260-6. PubMed ID: 21780183
[TBL] [Abstract][Full Text] [Related]
6. The effect of dopamine therapy on ventral and dorsal striatum-mediated cognition in Parkinson's disease: support from functional MRI.
MacDonald PA; MacDonald AA; Seergobin KN; Tamjeedi R; Ganjavi H; Provost JS; Monchi O
Brain; 2011 May; 134(Pt 5):1447-63. PubMed ID: 21596772
[TBL] [Abstract][Full Text] [Related]
7. Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation.
Thobois S; Ardouin C; Lhommée E; Klinger H; Lagrange C; Xie J; Fraix V; Coelho Braga MC; Hassani R; Kistner A; Juphard A; Seigneuret E; Chabardes S; Mertens P; Polo G; Reilhac A; Costes N; LeBars D; Savasta M; Tremblay L; Quesada JL; Bosson JL; Benabid AL; Broussolle E; Pollak P; Krack P
Brain; 2010 Apr; 133(Pt 4):1111-27. PubMed ID: 20237128
[TBL] [Abstract][Full Text] [Related]
8. Odor identification deficits identify Parkinson's disease patients with poor cognitive performance.
Damholdt MF; Borghammer P; Larsen L; Ostergaard K
Mov Disord; 2011 Sep; 26(11):2045-50. PubMed ID: 21638326
[TBL] [Abstract][Full Text] [Related]
9. Semantic and affective priming as a function of stimulation of the subthalamic nucleus in Parkinson's disease.
Castner JE; Chenery HJ; Copland DA; Coyne TJ; Sinclair F; Silburn PA
Brain; 2007 May; 130(Pt 5):1395-407. PubMed ID: 17430981
[TBL] [Abstract][Full Text] [Related]
10. The role of dopamine in cognitive sequence learning: evidence from Parkinson's disease.
Shohamy D; Myers CE; Grossman S; Sage J; Gluck MA
Behav Brain Res; 2005 Jan; 156(2):191-9. PubMed ID: 15582105
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory control during smooth pursuit in Parkinson's disease and Huntington's disease.
Henderson T; Georgiou-Karistianis N; White O; Millist L; Williams DR; Churchyard A; Fielding J
Mov Disord; 2011 Aug; 26(10):1893-9. PubMed ID: 21630355
[TBL] [Abstract][Full Text] [Related]
12. Attenuated neural response to gamble outcomes in drug-naive patients with Parkinson's disease.
van der Vegt JP; Hulme OJ; Zittel S; Madsen KH; Weiss MM; Buhmann C; Bloem BR; Münchau A; Siebner HR
Brain; 2013 Apr; 136(Pt 4):1192-203. PubMed ID: 23442226
[TBL] [Abstract][Full Text] [Related]
13. The basal ganglia and inhibitory mechanisms in response selection: evidence from subliminal priming of motor responses in Parkinson's disease.
Seiss E; Praamstra P
Brain; 2004 Feb; 127(Pt 2):330-9. PubMed ID: 14645146
[TBL] [Abstract][Full Text] [Related]
14. Subthalamic nucleus stimulation selectively improves motor and visual memory performance in Parkinson's disease.
Mollion H; Dominey PF; Broussolle E; Ventre-Dominey J
Mov Disord; 2011 Sep; 26(11):2019-25. PubMed ID: 21611980
[TBL] [Abstract][Full Text] [Related]
15. Slowing of oscillatory brain activity is a stable characteristic of Parkinson's disease without dementia.
Stoffers D; Bosboom JL; Deijen JB; Wolters EC; Berendse HW; Stam CJ
Brain; 2007 Jul; 130(Pt 7):1847-60. PubMed ID: 17412733
[TBL] [Abstract][Full Text] [Related]
16. Motor procedural learning in Parkinson's disease.
Muslimovic D; Post B; Speelman JD; Schmand B
Brain; 2007 Nov; 130(Pt 11):2887-97. PubMed ID: 17855374
[TBL] [Abstract][Full Text] [Related]
17. Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patients.
Merola A; Zibetti M; Angrisano S; Rizzi L; Ricchi V; Artusi CA; Lanotte M; Rizzone MG; Lopiano L
Brain; 2011 Jul; 134(Pt 7):2074-84. PubMed ID: 21666262
[TBL] [Abstract][Full Text] [Related]
18. Subthalamic nucleus stimulation and somatosensory temporal discrimination in Parkinson's disease.
Conte A; Modugno N; Lena F; Dispenza S; Gandolfi B; Iezzi E; Fabbrini G; Berardelli A
Brain; 2010 Sep; 133(9):2656-63. PubMed ID: 20802206
[TBL] [Abstract][Full Text] [Related]
19. The effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: a randomized, double-blind, placebo-controlled, multicenter study.
Hanagasi HA; Gurvit H; Unsalan P; Horozoglu H; Tuncer N; Feyzioglu A; Gunal DI; Yener GG; Cakmur R; Sahin HA; Emre M
Mov Disord; 2011 Aug; 26(10):1851-8. PubMed ID: 21500280
[TBL] [Abstract][Full Text] [Related]
20. Visual-spatial disembedding in Parkinson's disease.
Crucian GP; Armaghani S; Armaghani A; Foster PS; Burks DW; Skoblar B; Drago V; Heilman KM
J Clin Exp Neuropsychol; 2010 Feb; 32(2):190-200. PubMed ID: 19484649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
